Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-17 17:10 |
6K:Purple Biotech Announces $5 Million Registered Direct Offering.
|
English | 164.9 KB | ||
| 2023-10-17 17:10 |
6K:Purple Biotech Announces $5 Million Registered Direct Offering.
|
English | 36.6 KB | ||
| 2023-10-17 16:56 |
Prospectus supplement to amend the Prior Prospectus to reduce capacity of the A…
|
English | 99.6 KB | ||
| 2023-10-17 16:56 |
Prospectus supplement to amend the Prior Prospectus to reduce capacity of the A…
|
English | 36.6 KB | ||
| 2023-10-13 16:22 |
6K-Company Presentation
|
English | 25.7 MB | ||
| 2023-10-13 16:22 |
6K-Company Presentation
|
English | 36.7 KB | ||
| 2023-10-07 20:41 |
6K-Purple Biotech Reports Potential Biomarker Data Support CM24’s Mechanism of …
|
English | 164.0 KB | ||
| 2023-10-07 20:41 |
6K-Purple Biotech Reports Potential Biomarker Data Support CM24’s Mechanism of …
|
English | 36.4 KB | ||
| 2023-10-03 17:09 |
6K- Purple Biotech Reports Positive Interim and Preliminary Results from NT219 …
|
English | 194.4 KB | ||
| 2023-10-03 17:09 |
6K- Purple Biotech Reports Positive Interim and Preliminary Results from NT219 …
|
English | 36.5 KB | ||
| 2023-09-21 17:16 |
6K- Purple Biotech to Present New CM24 Pancreatic Cancer Biomarker Data at AACR…
|
English | 162.9 KB | ||
| 2023-09-21 17:16 |
6K- Purple Biotech to Present New CM24 Pancreatic Cancer Biomarker Data at AACR…
|
English | 36.5 KB | ||
| 2023-09-13 17:49 |
FORM 6-K- Company Presentation
|
English | 5.7 MB | ||
| 2023-09-13 17:49 |
FORM 6-K- Company Presentation
|
English | 36.5 KB | ||
| 2023-08-22 17:32 |
Second Quarter 2023 Financial Results
|
English | 246.2 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
